Article
[Prognostic significance of immunoglobulin variable region gene mutations in B-CLL patients treated with combination therapy fludarabine plus cyclophosphamide].
Terapevticheskii arkhiv - 1 Jan 2007
Nikitin E A, Stadnik E A, Lorie Iu Iu, Biderman B V, Tsyba N N, Salogub G N, Kolosheĭnova T I, Kolosova L Iu, Risinskaia N A, Zaritskiĭ Iu A, Kovaleva L G, Sudarikov A B
Abstract excerpt
AIM: To study prognostic factors in previously untreated patients receiving FC regimen (fludarabine plus cyclophosphamide). MATERIAL AND METHODS: We conducted a retrospective analysis of B-CLL patients observed in Hematology Research Center of Russia (Moscow) and Faculty Therapy Clinic of St. Petersburg State Medical University (St. Petersburg). All patients received FC regimen as a first line treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.